Eloise McLennan

An insightful interview with Peter Stenico, global head of biosimilars and country president, Sandoz Austria at Reuters Pharma Europe, Barcelona 2024

Gain insights into market access strategies for 2024 with a deep dive featuring perspectives from industry leaders such as Alexion, Putnam, Inizio Advisory, and insights from Reuters Pharma US.

Stay updated on the latest trends and developments in the pharmaceutical industry with Reuters Pharma Europe 2024. Get insights, analysis, and news related to pharmaceuticals in Europe.

Get insights and highlights from Day One of Reuters Pharma Europe 2024, focusing on the latest in technology and pharmaceutical advancements. Stay updated on key developments in the industry.

There is no denying that artificial intelligence (AI) has captured the imagination of innovators working across the pharmaceutical sector. The drug discovery space is no different, with myriad applications promising to revolutionise the way that researchers and sponsors approach identifying and progressing new drug candidates.

Accelerating innovation in rare diseases is crucial for improving diagnostics and treatment. Learn how Alexion and Soraya Bekkali are contributing to advancements in this field.

Explore the key aspects of clinical trial supply management, including insights on Clinigen and its role in supporting clinical research trials. Learn how this backbone of breakthroughs can drive success in clinical trials.

Gain insights into the research and development strategies of leading companies like Alexion, Samsung Biologics, JPM, UCB, and Clinigen with in-depth interviews and analysis for 2024.

Deep Dive: Digital Health 2023 | pharmaphorum - pharmaphorum

Deep Dive – Patients & Partnerships 2023 features interviews, analysis, and commentary from pharmaphorum, Lumanity, NIHR, Calculus Capital, M3, and more

New research from ViiV Healthcare has revealed a widespread gap in public knowledge and understanding of HIV worldwide

Myeloma Patients Europe (MPE) has identified significant inequalities among patients’ access to myeloma clinical trials in Central and Eastern

On Thursday, 17 November, Reuters opened the doors for its first European awards ceremony. The event brought together

X4 Pharmaceuticals has announced positive top-line results from a Phase 3 study of its lead investigational therapy, mavorixafor, in

On 14th November, investors and life science & healthcare executives descended on London’s famed Old Billingsgate building to attend LSX

As part of our Women in Pharma series, where we talk to leading figures in the life sciences, we hear from Şeyda Atadan Memiş

As part of our Women in Pharma series, where we talk to leading figures in the life sciences, we hear from Şeyda Atadan Memiş

For the first time, patients in England with triple-negative breast cancer (TNBC) will be able to access immunotherapy

In this new segment from pharmaphorum, we collect the most significant hirings, firings, and recruitment stories from across

Swiss pharma giant Roche has moved to strengthen its position in the KRAS-mutated cancer space through a $25 million licensing and collaboration agreement with Austrian arenaviral technology firm Hookipa Pharma.